Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
9265.T Stock Summary
Top 10 Correlated ETFs
9265.T
In the News
9265.T Financial details
Company Rating
-
Market Cap
5.48B
Income
216M
Revenue
58.75B
Book val./share
3117.65
Cash/share
1384.71
Dividend
46
Dividend %
2.17%
Employees
570
Optionable
No
Shortable
Yes
Earnings
04 Jan 2024
P/E
25.1
Forward P/E
-
PEG
-3.65
P/S
0.09
P/B
0.68
P/C
1.53
P/FCF
-
Quick Ratio
1.02
Current Ratio
1.25
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
84.99
EPS next Y
-
EPS next Q
-
EPS this Y
-68.52%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
8.7%
Revenue last 5Y
-1.11%
Revenue Q/Q
-14.87%
EPS Q/Q
-25.6%
-
-
-
-
SMA20
5.54%
SMA50
5.96%
SMA100
3.5%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
3%
ROC
0.13%
Gross Margin
14%
Oper. Margin
2%
Profit Margin
-
Payout
-
Shs Outstand
2.55M
Shs Float
1.05M
-
-
-
-
Target Price
-
52W Range
1505.0-2285.0
52W High
-7.05%
52W Low
+41.13%
RSI
60
Rel Volume
0.21
Avg Volume
2.87K
Volume
600
Perf Week
0.71%
Perf Month
8.15%
Perf Quarter
3.06%
Perf Half Y
0.19%
-
-
-
-
Beta
0.421
-
-
Volatility
13.13%, 66.38%
Prev Close
-0.7%
Price
2124
Change
-0.05%
9265.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-05-31
Metric | History | 2019-05-31 | 2020-05-31 | 2021-05-31 | 2022-05-31 | 2023-05-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 24.1K | 25.33K | 27.47K | 21.6K | 22.8K | |
Net income per share | 56.57 | 180.07 | 265.77 | 272.67 | 85.79 | |
Operating cash flow per share | -39.75 | 320.35 | 357.06 | 227.69 | 848.45 | |
Free cash flow per share | -64.73 | 300.29 | 299.78 | 181.25 | 816.72 | |
Cash per share | 784.41 | 1.02K | 1.27K | 1.38K | 2.12K | |
Book value per share | 2.5K | 2.72K | 2.97K | 3.13K | 3.1K | |
Tangible book value per share | 2.43K | 2.65K | 2.92K | 3.08K | 3.06K | |
Share holders equity per share | 2.5K | 2.72K | 2.97K | 3.13K | 3.1K | |
Interest debt per share | 1.32 | 0.96 | 1.64 | 1.51 | 0.78 | |
Market cap | 3.07B | 4.98B | 5.12B | 4.94B | 5.12B | |
Enterprise value | 738.2M | 1.96B | 1.47B | 969.2M | -706.46M | |
P/E ratio | 21.28 | 10.82 | 7.55 | 7.1 | 23.37 | |
Price to sales ratio | 0.05 | 0.08 | 0.07 | 0.09 | 0.09 | |
POCF ratio | -30.29 | 6.08 | 5.62 | 8.51 | 2.36 | |
PFCF ratio | -18.6 | 6.49 | 6.69 | 10.69 | 2.45 | |
P/B Ratio | 0.48 | 0.72 | 0.68 | 0.62 | 0.65 | |
PTB ratio | 0.48 | 0.72 | 0.68 | 0.62 | 0.65 | |
EV to sales | 0.01 | 0.03 | 0.02 | 0.02 | -0.01 | |
Enterprise value over EBITDA | 0.89 | 2.34 | 1.2 | 0.79 | -0.5 | |
EV to operating cash flow | -7.28 | 2.4 | 1.61 | 1.67 | -0.33 | |
EV to free cash flow | -4.47 | 2.56 | 1.92 | 2.09 | -0.34 | |
Earnings yield | 0.05 | 0.09 | 0.13 | 0.14 | 0.04 | |
Free cash flow yield | -0.05 | 0.15 | 0.15 | 0.09 | 0.41 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | -2.81 | -3.59 | -2.97 | -3.23 | -4.13 | |
Current ratio | 1.14 | 1.17 | 1.17 | 1.21 | 1.21 | |
Interest coverage | 154.71 | 228.6 | 231.56 | 241.19 | 578 | |
Income quality | -0.27 | 1.27 | 0.87 | 0.57 | 3.41 | |
Dividend Yield | 0.02 | 0.02 | 0.03 | 0.05 | 0.04 | |
Payout ratio | 0.46 | 0.23 | 0.2 | 0.33 | 0.95 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Capex to operating cash flow | 0.63 | -0.06 | -0.16 | -0.2 | -0.04 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | -0.3 | -0.27 | -0.74 | -0.53 | -0.4 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.78K | 3.32K | 4.21K | 4.38K | 2.44K | |
ROIC | 0.03 | 0.06 | 0.08 | 0.08 | 0.05 | |
Return on tangible assets | 0.01 | 0.02 | 0.03 | 0.03 | 0.01 | |
Graham Net | -1.21K | -1.14K | -1.14K | -890.27 | -754.93 | |
Working capital | 1.89B | 2.34B | 2.74B | 3.24B | 3.38B | |
Tangible asset value | 6.2B | 6.78B | 7.45B | 7.86B | 7.81B | |
Net current asset value | 1.19B | 1.58B | 2.24B | 2.71B | 2.87B | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 10.18B | 10.13B | 11.13B | 12.01B | 11.18B | |
Average payables | 8.08B | 7.55B | 7.88B | 8.09B | 7.84B | |
Average inventory | 2.4B | 2.62B | 2.85B | 2.83B | 2.82B | |
Days sales outstanding | 60.14 | 57.19 | 63.16 | 78.69 | 65.71 | |
Days payables outstanding | 50.63 | 47.1 | 48.33 | 60.78 | 56.72 | |
Days of inventory on hand | 16.55 | 17.37 | 17.22 | 20.88 | 21.24 | |
Receivables turnover | 6.07 | 6.38 | 5.78 | 4.64 | 5.55 | |
Payables turnover | 7.21 | 7.75 | 7.55 | 6.01 | 6.43 | |
Inventory turnover | 22.06 | 21.01 | 21.2 | 17.48 | 17.19 | |
ROE | 0.02 | 0.07 | 0.09 | 0.09 | 0.03 | |
Capex per share | -24.98 | -20.06 | -57.28 | -46.44 | -31.73 |
Quarterly Fundamentals Overview
Last date of statement is 2023-08-31 for Q1
Metric | History | 2022-08-31 | 2022-11-30 | 2023-02-28 | 2023-05-31 | 2023-08-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 5.28K | 5.56K | 5.51K | 6.45K | 5.49K | |
Net income per share | 64.63 | -143.37 | 79.13 | 85.39 | 63.46 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 574.25 | 709.78 | 1.28K | 2.12K | 1.38K | |
Book value per share | 3.14K | 2.97K | 3.01K | 3.1K | 3.12K | |
Tangible book value per share | 3.1K | 2.93K | 2.98K | 3.06K | 3.07K | |
Share holders equity per share | 3.14K | 2.97K | 3.01K | 3.1K | 3.12K | |
Interest debt per share | 0 | 0.39 | 0 | 0.39 | 6.66 | |
Market cap | 4.16B | 4.13B | 4.56B | 5.12B | 4.96B | |
Enterprise value | 2.7B | 2.32B | 1.29B | -706.46M | 1.44B | |
P/E ratio | 6.3 | -2.82 | 5.64 | 5.87 | 7.65 | |
Price to sales ratio | 0.31 | 0.29 | 0.32 | 0.31 | 0.35 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0.52 | 0.54 | 0.59 | 0.65 | 0.62 | |
PTB ratio | 0.52 | 0.54 | 0.59 | 0.65 | 0.62 | |
EV to sales | 0.2 | 0.16 | 0.09 | -0.04 | 0.1 | |
Enterprise value over EBITDA | 9.8 | 6.61 | 4.13 | -2.61 | 6.72 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0.04 | -0.09 | 0.04 | 0.04 | 0.03 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | -5.33 | -5.16 | -10.47 | -21.49 | -16.44 | |
Current ratio | 1.23 | 1.21 | 1.23 | 1.21 | 1.25 | |
Interest coverage | 0 | 339 | 0 | 261 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0.09 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0 | 0.01 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.14K | 3.1K | 2.32K | 2.44K | 2.11K | |
ROIC | 0.02 | 0.06 | 0.02 | 0.02 | 0.01 | |
Return on tangible assets | 0.01 | -0.02 | 0.01 | 0.01 | 0.01 | |
Graham Net | -905.05 | -1K | -706.06 | -754.93 | -618.32 | |
Working capital | 3.3B | 3.06B | 3.3B | 3.38B | 3.53B | |
Tangible asset value | 7.9B | 7.48B | 7.6B | 7.81B | 7.84B | |
Net current asset value | 2.67B | 2.4B | 2.69B | 2.87B | 2.98B | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 12.45B | 12.69B | 11.63B | 10.68B | 10.61B | |
Average payables | 8.23B | 8.42B | 8.02B | 7.77B | 7.87B | |
Average inventory | 2.8B | 3.06B | 3.16B | 3B | 2.9B | |
Days sales outstanding | 86.97 | 78.43 | 69.68 | 57.25 | 68.99 | |
Days payables outstanding | 66.25 | 60.68 | 57.68 | 49.64 | 58.85 | |
Days of inventory on hand | 22.33 | 23.64 | 22.98 | 18.59 | 21.28 | |
Receivables turnover | 1.03 | 1.15 | 1.29 | 1.57 | 1.3 | |
Payables turnover | 1.36 | 1.48 | 1.56 | 1.81 | 1.53 | |
Inventory turnover | 4.03 | 3.81 | 3.92 | 4.84 | 4.23 | |
ROE | 0.02 | -0.05 | 0.03 | 0.03 | 0.02 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
9265.T Frequently Asked Questions
What is Yamashita Health Care Holdings,Inc. stock symbol ?
Yamashita Health Care Holdings,Inc. is a JP stock and trading under the symbol 9265.T
What is Yamashita Health Care Holdings,Inc. stock quote today ?
Yamashita Health Care Holdings,Inc. stock price is $2124 today.
Is Yamashita Health Care Holdings,Inc. stock public?
Yes, Yamashita Health Care Holdings,Inc. is a publicly traded company.